FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3044381505> ?p ?o ?g. }

• W3044381505 endingPage "6" @default.
• W3044381505 startingPage "5" @default.
• W3044381505 abstract "Microscopic colitis (MC) is a chronic inflammatory bowel disease, divided into collagenous colitis (CC) and lymphocytic colitis (LC). The most common symptom of MC is chronic watery, non-bloody diarrhoea, but other gastrointestinal symptoms such as abdominal pain and bloating are also frequently observed.1 The chronic watery diarrhoea leads to great inconveniences for the patient, with faecal urgency, nocturnal stools and faecal incontinence. As the disease may have vague and non-specific signs on endoscopy, histopathological diagnosis is mandatory, which is unfortunately sometimes overlooked. The clinical handling of the patient may be a challenge, because the symptoms may be refractory to conventional treatment.2 In the current issue of the United European Gastroenterology Journal, the United European Gastroenterology and the European Microscopic Colitis Group present their statements and recommendations for the disease in the European guidelines on MC.3 These guidelines are developed after an impressive research and assessment of published literature within the field. The systematic review was performed in accordance with the PRISMA guidelines, and the GRADE methodology was applied to assess the quality of the studies. Meta-analyses were conducted when applicable. The publication is presented as answers to the most common questions regarding epidemiology, sex differences, lifestyle habits, aetiology and pathogenesis, clinical manifestations, assessment of disease activity, diagnostic criteria and treatment options. For each question and answer, the level of evidence, the strength of recommendation and the degree of consensus within the working group are given. Through this well-structured presentation, the guidelines are easy to understand and to follow. The report has settled the diagnostic criteria for CC as a thickened subepithelial collagenous band of 10 mm or greater combined with an increased mixed inflammatory infiltrate in the lamina propria. The diagnostic criteria for LC are an increased number of intraepithelial lymphocytes of 20/100 or more surface epithelial cells combined with an increased mixed inflammatory infiltrate in the lamina propria and a normal collagenous band. A third, recently identified subgroup, incomplete MC, is also described. The value of different examinations for the diagnosis of MC is discussed, and common diseases which are important to exclude before the final diagnosis is made. MC is recommended to be ruled out in patients considered to have functional diarrhoea or irritable bowel syndrome with predominant diarrhoea, and all patients with MC should be screened for coeliac disease. A strict coherence in diagnosing is important, especially when considering chronic diseases which will follow the patients through the rest of their lives. Before the diagnosis of MC is made, even when the histopathological criteria are fulfilled, it must be ascertained that the disease is a chronic disease, and not only a temporary diarrhoea episode due to an infectious gastroenteritis or drug use.4 Overconsumption of alcohol has been described in patients with MC,5 and may be one explanation for chronic diarrhoea, which may be handled quite differently. Misuse of laxatives is another diagnosis to exclude, which may be difficult to identify in women in these age groups. Several systemic diagnoses may have LC as a part of the general syndrome, and the colitis in these cases should be considered as a part of the general disease and not as a separate entity.6 To give the patient an incorrect diagnosis may lead to less optimal treatment and heterogeneous research cohorts, with data difficult to reproduce. The pooled overall prevalence of MC is estimated to be 119 (95% confidence interval 73–166) per 100,000 inhabitants; LC is slightly more common than CC.1 The disease is more common in women than in men. Smoking and some drugs are associated with the disease, although the causal mechanism cannot be proved. Complications commonly associated with Crohn's disease or ulcerative colitis; for example, malignancy and liver diseases, are not associated with MC.7 Thus, the pathophysiology in MC should differ from the pathophysiology in classic inflammatory bowel disease. Budesonide is the recommended drug of choice, both for remission and maintenance of the disease. There is no evidence of severe adverse effects of this drug in long-term use. Faecal calprotectin and histological monitoring are of no use in the course of MC. Instead, the disease activity and clinical remission should be assessed by the Hjortswang criteria.8 When patients fail to respond to budesonide, thiopurines, anti-tumour necrosis factor drugs or vedolizumab can be used in selected patients. Other drugs, such as mesalazine, bismuth subsalicylate, probiotics, corticosteroids and methotrexate, are not recommended. In conclusion, these guidelines on MC are a very comprehensive review of important background aspects, but most of all, a practical guide on how to handle MC in the everyday work in the clinical praxis. The author has no conflict of interest to declare." @default.
• W3044381505 created "2020-07-29" @default.
• W3044381505 creator A5028869223 @default.
• W3044381505 date "2021-02-01" @default.
• W3044381505 modified "2023-09-30" @default.
• W3044381505 title "New European statements and recommendations for the management of microscopic colitis" @default.
• W3044381505 cites W1996414702 @default.
• W3044381505 cites W2020299608 @default.
• W3044381505 cites W2166021109 @default.
• W3044381505 cites W2506961821 @default.
• W3044381505 cites W2559448577 @default.
• W3044381505 cites W2922476638 @default.
• W3044381505 cites W3011181874 @default.
• W3044381505 doi "https://doi.org/10.1177/2050640620945811" @default.
• W3044381505 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8259267" @default.
• W3044381505 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32703082" @default.
• W3044381505 hasPublicationYear "2021" @default.
• W3044381505 type Work @default.
• W3044381505 sameAs 3044381505 @default.
• W3044381505 citedByCount "1" @default.
• W3044381505 countsByYear W30443815052021 @default.
• W3044381505 crossrefType "journal-article" @default.
• W3044381505 hasAuthorship W3044381505A5028869223 @default.
• W3044381505 hasBestOaLocation W30443815051 @default.
• W3044381505 hasConcept C107130276 @default.
• W3044381505 hasConcept C121608353 @default.
• W3044381505 hasConcept C126322002 @default.
• W3044381505 hasConcept C137627325 @default.
• W3044381505 hasConcept C177713679 @default.
• W3044381505 hasConcept C2775862500 @default.
• W3044381505 hasConcept C2776153500 @default.
• W3044381505 hasConcept C2776956441 @default.
• W3044381505 hasConcept C2778260677 @default.
• W3044381505 hasConcept C2778435480 @default.
• W3044381505 hasConcept C2778561856 @default.
• W3044381505 hasConcept C2779134260 @default.
• W3044381505 hasConcept C2780437304 @default.
• W3044381505 hasConcept C2780955771 @default.
• W3044381505 hasConcept C526805850 @default.
• W3044381505 hasConcept C71924100 @default.
• W3044381505 hasConcept C90924648 @default.
• W3044381505 hasConceptScore W3044381505C107130276 @default.
• W3044381505 hasConceptScore W3044381505C121608353 @default.
• W3044381505 hasConceptScore W3044381505C126322002 @default.
• W3044381505 hasConceptScore W3044381505C137627325 @default.
• W3044381505 hasConceptScore W3044381505C177713679 @default.
• W3044381505 hasConceptScore W3044381505C2775862500 @default.
• W3044381505 hasConceptScore W3044381505C2776153500 @default.
• W3044381505 hasConceptScore W3044381505C2776956441 @default.
• W3044381505 hasConceptScore W3044381505C2778260677 @default.
• W3044381505 hasConceptScore W3044381505C2778435480 @default.
• W3044381505 hasConceptScore W3044381505C2778561856 @default.
• W3044381505 hasConceptScore W3044381505C2779134260 @default.
• W3044381505 hasConceptScore W3044381505C2780437304 @default.
• W3044381505 hasConceptScore W3044381505C2780955771 @default.
• W3044381505 hasConceptScore W3044381505C526805850 @default.
• W3044381505 hasConceptScore W3044381505C71924100 @default.
• W3044381505 hasConceptScore W3044381505C90924648 @default.
• W3044381505 hasIssue "1" @default.
• W3044381505 hasLocation W30443815051 @default.
• W3044381505 hasLocation W30443815052 @default.
• W3044381505 hasOpenAccess W3044381505 @default.
• W3044381505 hasPrimaryLocation W30443815051 @default.
• W3044381505 hasRelatedWork W112246212 @default.
• W3044381505 hasRelatedWork W1591931848 @default.
• W3044381505 hasRelatedWork W1978239722 @default.
• W3044381505 hasRelatedWork W1989042761 @default.
• W3044381505 hasRelatedWork W2113107751 @default.
• W3044381505 hasRelatedWork W2163484143 @default.
• W3044381505 hasRelatedWork W2912461528 @default.
• W3044381505 hasRelatedWork W2984501306 @default.
• W3044381505 hasRelatedWork W3142004793 @default.
• W3044381505 hasRelatedWork W4382724419 @default.
• W3044381505 hasVolume "9" @default.
• W3044381505 isParatext "false" @default.
• W3044381505 isRetracted "false" @default.
• W3044381505 magId "3044381505" @default.
• W3044381505 workType "article" @default.